Shopping Cart
Remove All
Your shopping cart is currently empty
IXA6, a novel IRE1/XBP1s agonist with potential vasoprotective activity, activates IRE1-XBP1s signaling and XBP1s transcriptional response, making it useful for studying neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $299 | - | In Stock |
| Description | IXA6, a novel IRE1/XBP1s agonist with potential vasoprotective activity, activates IRE1-XBP1s signaling and XBP1s transcriptional response, making it useful for studying neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. |
| In vitro | IXA6 ( 10μM ; 4 or 18h ) selectively activates IRE1-XBP1s signaling, activates IRE1 to reduce APP secretion, and selectively reshapes IRE1-XBP1s-dependent ER protein homeostasis. |
| Molecular Weight | 441.93 |
| Formula | C22H20ClN3O3S |
| Cas No. | 1021106-40-0 |
| Smiles | ClC1=CC=C(CN(CC(=O)N2CCC3=C2C=CC=C3)S(=O)(=O)C2=CC=CN=C2)C=C1 |
| Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.